REMEDi4ALL
@remedi4all.bsky.social
The European Platform for Medicines Repurposing. Funded by #HorizonEurope. remedi4all.org
💊 Could existing medicines help tackle excessive inflammation? New #REMEDi4ALL research explores patient-derived cell models as tools to screen drug repurposing candidates targeting cytokine-driven inflammation. 🔗 Read the study in Nature Scientific Reports: https://loom.ly/IJLf0Aw
Four reasons why you shouldn’t miss #iDR27 👇 From science with real-world impact to international collaboration, global perspectives and conversations shaping the future of drug repurposing, there’s plenty to explore at iDR27. 📍 London | 15–16 June 2027 🔗 remedi4all.org/idr27
👥 What can participants expect from the REMEDi4ALL Repurposing Bootcamp for Patient Representatives? Swipe through to hear from the organisers about the programme and what participants will take away. 👉 Find out more and apply before 9 November: https://loom.ly/H2FxxGE
💊 On 5 November, REMEDi4ALL’s Martin de Kort will join speakers at a workshop organised by the Global Pharmaceutical and Society Studies (GPSS) Network. The event will bring together the drug innovation ecosystem for a day of conversation and mutual learning. 🔗 https://loom.ly/sqkphxE
What did participants value most about last year’s REMEDi4ALL Patient Representatives Bootcamp? Swipe through to read their testimonials. Applications are open for the next Repurposing Bootcamp, taking place in Barcelona on 10–11 June 2027. 👉 Learn more and apply: https://loom.ly/H2FxxGE
📚 What makes a drug repurposing project valuable? A new REMEDi4ALL study presents 37 assessment criteria designed to support more transparent and evidence-informed evaluation of drug repurposing initiatives. The framework is also available as a free practical tool. 👉More: https://loom.ly/1FMNNww
🔊The conversations started at #iDR26 in Brussels will continue at #iDR27! Join the international drug repurposing community in London on 15-16 June 2027 for two days of discussion, collaboration and shared learning. 🎟️Early Bird registration now open➡️https://loom.ly/E3SWtLo
📢 Applications extended for the REMEDi4ALL Repurposing Bootcamp for Patient Representatives! Join us to build the knowledge and practical skills to help advance promising drug repurposing opportunities towards patient impact. 👉 Learn more and apply today: https://loom.ly/H2FxxGE
📣 The International Drug Repurposing Conference (#iDR27) by REMEDi4ALL and Beacon for Rare Diseases returns on 15–16 June 2027 in London under the theme “Further, Together: From Science to Patient Impact”! 👉 Discover iDR27 and claim your early-bird discount now: https://loom.ly/P6-l0RQ
That’s a wrap on GAM5! 🎉 In Hamburg, the REMEDi4ALL consortium reflected on key achievements and lessons from the past year—and looked ahead to securing the project’s long-term impact on drug repurposing. 👏 Thank you to Fraunhofer for hosting and to partners for such productive discussions!
🎥REMEDi4ALL Hackathon 2026 Highlights Video is now live! Discover how early-career researchers gained hands-on experience in drug repurposing through a week of collaboration, learning and real-world challenges. 📺Watch the reel: https://loom.ly/ev-eKQI 🔗Read the recap: https://loom.ly/czEAwGk
What can you expect at the REMEDi4ALL Repurposing Bootcamp for Patient Representatives? Taking place on 10–11 June 2027 in Barcelona, the Bootcamp is designed for representatives of patient organisations based in the EU and UK! 🔗 Apply here before 16 October: https://loom.ly/H2FxxGE
🔍 Did you know REMEDi4ALL has published 30+ open-access papers on drug repurposing? 📚From AI-powered tools and policy research to rare diseases and real-world case studies, explore the latest findings: https://loom.ly/TxjYWsc
📢 Build the knowledge and practical skills to help advance promising drug repurposing opportunities towards patient impact! Join the REMEDi4ALL Repurposing Bootcamp for Patient Representatives on 10–11 June 2027 in Barcelona. 🔗 Apply here before 16 October: https://loom.ly/H2FxxGE
💊 Yesterday at #RExPO26 in Berlin, Patricia Vandamme of the Anticancer Fund presented the session “REMEDi4ALL – Building a sustainable platform, strengthening the Drug Repurposing ecosystem”. 👉 Read the session abstract here: https://loom.ly/yR3jKTw
This year’s REMEDi4ALL Hackathon brought together 15 early-career researchers, experts and patient representatives to explore drug repurposing opportunities for three rare neurodevelopmental disorders. Thank you to everyone involved! 👉 Read the full event summary here: https://loom.ly/czEAwGk
Join us at the #REMEDi4ALL Repurposing Bootcamp in Barcelona on 10-11 June 2027! A unique chance to learn, collaborate & share through lectures, workshops, and discussions. Apply now! 🔗 https://loom.ly/H2FxxGE
👏 That's a wrap on the 2026 REMEDi4ALL Hackathon! 🏆 Congratulations to the winning team, representing SATB2-associated syndrome, and to all teams for their excellent work, dedication and collaborative spirit throughout the hackathon. Stay tuned for more insights and highlights!
💻 The REMEDi4ALL Hackathon continues in Montserrat, Spain! Participants have been diving deep into databases, exploring and prioritising potential drug repurposing candidates for neurodevelopmental disorders. 💫 Stay tuned for more insights from the Hackathon this week!
💊 The REMEDi4ALL #Hackathon is underway in Montserrat! Following a visit to the Montserrat Monastery, participants have explored drug repurposing through REPURPOLIS and computational sessions. Next up: patient engagement, TPPs, eHTA and routes to market. #REMEDi4ALL
📄 A recent article from Inside Precision Medicine highlights REMEDi4ALL’s work with partners EURORDIS and Fraunhofer ITMP to support researchers and patient organisations across the repurposing pathway. 🔗 https://loom.ly/YVW3Zp8
Are you a patient representative curious about #DrugRepurposing? Join us at the #REMEDi4ALL Repurposing Bootcamp in Barcelona on 10-11 June 2027! A unique chance to learn, collaborate & share through lectures, workshops, and discussions. Apply now! 🔗 https://loom.ly/H2FxxGE
📢 New REMEDi4ALL publication! A new study presents a scalable drug repurposing approach that uses cell painting and morphological profiling to identify potential antiviral candidates to support future antiviral research and pandemic preparedness! 🔗 https://loom.ly/2CtU5YE
💊 The MOI-A study is investigating the potential of losartan as a treatment for older adolescents and adults living with this rare genetic bone disorder. As Alessandra Tolaccia of OIFE explains, the potential impact for adult patients is deeply personal. 👉 Learn more: https://loom.ly/uaJ_YgA
🌎 REMEDi4ALL Scientific Lead Don Lo contributed to an FDA-supported meeting on advancing drug repurposing opportunities towards regulatory approval and patient access. Don emphasised, “Translation is a team sport.” Progress requires coordinated expertise across sectors. 🔗https://loom.ly/EEind5M
Join the 'Medicines Reimagined' Forum, where enthusiasts and experts in drug repurposing unite! Connect, collaborate, share insights, and explore the challenges and successes in the #DrugRepurposing field. 👉 Join the dialogue today: https://remedi4all.org/stakeholder-forum
💊 Build your knowledge of drug repurposing with the REMEDi4ALL Digital Academy. This free online learning platform offers accessible, expert-led training for researchers, patient organisations, industry representatives. 👉 Start learning today: https://loom.ly/6FQD_TQ
🌍 On #MSDWorldDay, REMEDi4ALL stands with families affected by multiple sulfatase deficiency. Our demonstrator project is investigating whether tazarotene could be repurposed as a treatment for MSD, working closely with patient champion Alan Finglas. 👉Learn more: https://loom.ly/rfokBf8
💊 The MOI-A study, a REMEDi4ALL demonstrator project, is investigating the potential of losartan as a treatment for older adolescents and adults living with this rare genetic bone disorder. 👉 Learn more and find out how patients and families can get involved here: https://loom.ly/uaJ_YgA
